Amdocs Media’s Vubiquity Continues Content Licensing and Services Partnership with Israel’s Cellcom
11 November 2020 - 8:05AM
Vubiquity, part of the Amdocs (NASDAQ: DOX) Media Division and one
of the leading global providers of premium content services and
media technology solutions, today announced it has signed a
multi-year extension to its current partnership with Cellcom Israel
Ltd., to provide licensing and processing for its leading premium
content service Cellcom TV with more than 245,000 subscribers.
Vubiquity holds relationships with over 1,400 content owners,
bringing the latest-release content from major studios, plus
leading global independent and library classics to provide the best
purchased content to Cellcom TV’s customers, including premium
content such as HBO, Disney, Warner and NBCU.
Darcy Antonellis, Head of Amdocs Media, said that: “We are
extremely pleased to have seized the opportunity to continue our
relationship with Cellcom, supporting its highly differentiated and
personalized Cellcom TV service, and providing its customers with a
best-in-class experience.”
This latest agreement between Amdocs and Cellcom follows an
announcement made earlier this year around a deal to accelerate the
digitization of Cellcom’s systems, in order to offer its customers
an advanced and intuitive digital experience across its
lines-of-business.
Supporting Resources
- Learn more about Amdocs Media’s
Vubiquity portfolio
- Keep up with Amdocs
news by visiting the company’s website
- Subscribe to Amdocs’
RSS Feed and follow us on Twitter, Facebook, LinkedIn and
YouTube
About Amdocs Amdocs’ purpose is to enrich lives
and progress society, using creativity and technology to build a
better connected world. Amdocs and its 26,000 employees partner
with the leading players in the communications and media industry,
enabling next-generation experiences in 85 countries. Our
cloud-native, open and dynamic portfolio of digital solutions,
platforms and services brings greater choice, faster time to market
and flexibility, to better meet the evolving needs of our customers
as they drive growth, transform and take their business to the
cloud. Listed on the NASDAQ Global Select Market, Amdocs had
revenue of $4.2 billion in fiscal 2020. For more information, visit
Amdocs at www.amdocs.com.
Amdocs’ Forward-Looking Statement
This press release includes information that
constitutes forward-looking statements made pursuant to the safe
harbor provision of the Private Securities Litigation Reform Act of
1995, including statements about Amdocs’ growth and business
results in future quarters. Although we believe the expectations
reflected in such forward-looking statements are based upon
reasonable assumptions, we can give no assurance that our
expectations will be obtained or that any deviations will not be
material. Such statements involve risks and uncertainties that may
cause future results to differ from those anticipated. These risks
include, but are not limited to, the effects of general economic
conditions, Amdocs’ ability to grow in the business markets that it
serves, Amdocs’ ability to successfully integrate acquired
businesses, adverse effects of market competition, rapid
technological shifts that may render the Company's products and
services obsolete, potential loss of a major customer, our ability
to develop long-term relationships with our customers, and risks
associated with operating businesses in the international market.
Amdocs may elect to update these forward-looking statements at some
point in the future; however, the Company specifically disclaims
any obligation to do so. These and other risks are discussed at
greater length in Amdocs’ filings with the Securities and Exchange
Commission, including in our Annual Report on Form 20-F for the
fiscal year ended September 30, 2019 filed on December 16, 2019 and
our quarterly Form 6-K furnished for the first quarter of fiscal
2020 on February 18, 2020 the second quarter of fiscal 2020 on May
18, 2020 and the third quarter of fiscal 2020 on August 17,
2020.
Media Contacts:
Nick BoultonAmdocs Public RelationsTel: +44 (0)7896 931
335E-mail: nicholas.boulton@amdocs.com
Paul CampbellBabel PR for AmdocsTel: +44 (0)20 7434 5552E-mail:
paul@babelpr.com
Amdocs (NASDAQ:DOX)
Historical Stock Chart
From Jun 2024 to Jul 2024
Amdocs (NASDAQ:DOX)
Historical Stock Chart
From Jul 2023 to Jul 2024